Literature DB >> 18602992

Microcrystalline cellulose, a useful alternative for sucrose as a matrix former during freeze-drying of drug nanosuspensions - a case study with itraconazole.

Bernard Van Eerdenbrugh1, Sofie Vercruysse, Johan A Martens, Jan Vermant, Ludo Froyen, Jan Van Humbeeck, Guy Van den Mooter, Patrick Augustijns.   

Abstract

Itraconazole nanosuspensions, stabilized with 10% TPGS (relative to the weight of itraconazole), were transformed into nanoparticulate powders by freeze-drying. The crystalline itraconazole nanoparticles showed peak broadening in the X-ray powder diffraction spectra and a lower melting point as inferred from differential scanning calorimetry. As it was found that freeze-drying compromised dissolution behavior, sucrose was added as a matrix, former (50,100 and 200%, relative to the weight of itraconazole). Higher amounts of sucrose unexpectedly resulted in a decrease in the dissolution rate. After thorough evaluation of the powders, it was found that whereas higher sucrose content showed a cryoprotective effect, agglomeration during the final phase of the subsequent drying step tended to increase with higher amounts of sucrose. Therefore, microcrystalline cellulose (MCC) was evaluated as an alternative matrix former. The inclusion of MCC resulted in fast dissolution that increased with increasing amounts of MCC [for powders containing 50%,100% and 200% MCC, (relative to the weight of itraconazole), the times required for 63.2% release were 10.5+/-0.7, 6.4+/-1.2 and 3.1+/-0.5min, respectively]. The dissolution profiles showed an initial phase of burst dissolution, followed by a phase of slower release. As the fraction showing burst dissolution increased with higher MCC content, the system holds promise to maintain the dissolution enhancing properties of nanoparticles in the dry form.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18602992     DOI: 10.1016/j.ejpb.2008.06.007

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  8 in total

1.  Formulation and stability testing of itraconazole crystalline nanoparticles.

Authors:  Alia A Badawi; Mohamed Ahmed El-Nabarawi; Doaa Ahmed El-Setouhy; Sami Ahmed Alsammit
Journal:  AAPS PharmSciTech       Date:  2011-06-25       Impact factor: 3.246

2.  Formulation and performance of danazol nano-crystalline suspensions and spray dried powders.

Authors:  Sumit Kumar; Rajan Jog; Jie Shen; Banu Zolnik; Nakissa Sadrieh; Diane J Burgess
Journal:  Pharm Res       Date:  2014-11-11       Impact factor: 4.200

Review 3.  Bioavailability Enhancement of Poorly Water-Soluble Drugs via Nanocomposites: Formulation⁻Processing Aspects and Challenges.

Authors:  Anagha Bhakay; Mahbubur Rahman; Rajesh N Dave; Ecevit Bilgili
Journal:  Pharmaceutics       Date:  2018-07-08       Impact factor: 6.321

Review 4.  Application of drug nanocrystal technologies on oral drug delivery of poorly soluble drugs.

Authors:  Lei Gao; Guiyang Liu; Jianli Ma; Xiaoqing Wang; Liang Zhou; Xiang Li; Fang Wang
Journal:  Pharm Res       Date:  2012-10-17       Impact factor: 4.200

5.  Preparation, characterization and pharmacokinetics of cyadox nanosuspension.

Authors:  Adeel Sattar; Dongmei Chen; Lishun Jiang; Yuanhu Pan; Yanfei Tao; Lingli Huang; Zhenli Liu; Shuyu Xie; Zonghui Yuan
Journal:  Sci Rep       Date:  2017-05-23       Impact factor: 4.379

6.  Novel nanocrystal-based solid dispersion with high drug loading, enhanced dissolution, and bioavailability of andrographolide.

Authors:  Yueqin Ma; Yang Yang; Jin Xie; Junnan Xu; Pengfei Yue; Ming Yang
Journal:  Int J Nanomedicine       Date:  2018-06-28

7.  Process optimization and evaluation of novel baicalin solid nanocrystals.

Authors:  Peng-Fei Yue; Yu Li; Jing Wan; Yong Wang; Ming Yang; Wei-Feng Zhu; Chang-Hong Wang; Hai-Long Yuan
Journal:  Int J Nanomedicine       Date:  2013-08-09

Review 8.  Emerging role of nanosuspensions in drug delivery systems.

Authors:  Shery Jacob; Anroop B Nair; Jigar Shah
Journal:  Biomater Res       Date:  2020-01-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.